📰 Bracanalysis Cdx News
Page 3 - Bracanalysis Cdx News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Bracanalysis Cdx. Real-time updates on events, politics, business and more.
August 31, 2022
Myriad Genetics' EndoPredict test accurately identified premenopausal women with ER+, HER2- breast cancer who could safely avoid adjuvant chemotherapy SALT LAKE CITY, Aug. 31, 2022 1 that shows the
August 25, 2022
SALT LAKE CITY, Aug. 25, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today...
August 16, 2022
Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, FranceLatest expansions represent Myriad's commitment to growing international lab partner program SALT LAKE CITY, Aug.
August 16, 2022
Collaboration brings MyChoice CDx Plus Testing to Hamburg, Germany and Dijon, FranceLatest expansions represent Myriad’s commitment to growing...
July 19, 2022
19.07.2022 - SALT LAKE CITY, July 19, 2022 (GLOBE NEWSWIRE) - Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will host an Investor Day on Aug. 11, 2022, providing a strategic business update and overview of the ...
July 19, 2022
SALT LAKE CITY, July 19, 2022 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, will host an...
July 12, 2022
Study showed PGx testing helps clinicians prescribe fewer medications with gene-drug interactions...
June 29, 2022
2021 report demonstrates focus on ESG initiatives supporting health equity, social justice, and sustainabilitySALT LAK...
June 23, 2022
Healthcare providers can easily order Myriad’s genetic tests for the more than 250 million patients within Epic’s networkPartnership bolsters Myriad’s growth plan to scale... | June 23, 2022
June 9, 2022
SALT LAKE CITY, June 09, 2022 (GLOBE NEWSWIRE) -- Paul J. Diaz, president and CEO of Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing...